Wave Life Sciences Ltd (WVE)

Nov 20, 2024

Wave Life Sciences Advances RNA Medicine Innovations - TipRanks

Nov 20, 2024

Nov 18, 2024

B. Riley Cuts Earnings Estimates for Wave Life Sciences - MarketBeat

Nov 18, 2024

Nov 18, 2024

HC Wainwright Has Pessimistic Outlook of WVE FY2024 Earnings - MarketBeat

Nov 18, 2024

Nov 17, 2024

Trading (WVE) With Integrated Risk Controls - Stock Traders Daily

Nov 17, 2024

Nov 17, 2024

Insider Sale: President and CEO Paul Bolno Sells 51,234 Shares o - GuruFocus.com

Nov 17, 2024

Nov 16, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) CEO Sells $733,670.88 in Stock - MarketBeat

Nov 16, 2024

Nov 15, 2024

Wave Life Sciences CEO Paul Bolno sells shares for $733,670 By Investing.com - Investing.com UK

Nov 15, 2024

Nov 15, 2024

Wave Life Sciences CEO Paul Bolno sells shares for $733,670 - Investing.com India

Nov 15, 2024

Nov 15, 2024

WVEWave Life Sciences Ltd. Ordinary Shares Latest Stock News & Market Updates - StockTitan

Nov 15, 2024

Nov 15, 2024

What is HC Wainwright's Forecast for WVE FY2028 Earnings? - MarketBeat

Nov 15, 2024

Nov 15, 2024

Wave Life Sciences to Present at Jefferies London Healthcare Conference - The Manila Times

Nov 15, 2024

Nov 15, 2024

What is B. Riley's Estimate for WVE Q1 Earnings? - MarketBeat

Nov 15, 2024

Nov 15, 2024

US$22.20That's What Analysts Think Wave Life Sciences Ltd. (NASDAQ:WVE) Is Worth After These Results - Simply Wall St

Nov 15, 2024

Nov 15, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) Released Earnings Last Week And Analysts Lifted Their Price Target To US$22.20 - Yahoo Finance

Nov 15, 2024

Nov 15, 2024

Leerink Partnrs Has Bullish Forecast for WVE FY2024 Earnings - MarketBeat

Nov 15, 2024

Nov 14, 2024

Wave Life Sciences Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St

Nov 14, 2024

Nov 14, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) Short Interest Update - MarketBeat

Nov 14, 2024

Nov 13, 2024

WaVe Life Sciences's SWOT analysis: RNA editing stock faces pivotal year - Investing.com

Nov 13, 2024

Nov 13, 2024

Wave Life Sciences executive sells shares worth $576,000 By Investing.com - Investing.com Nigeria

Nov 13, 2024

Nov 13, 2024

Wave Life Sciences executive sells shares worth $576,000 - Investing.com India

Nov 13, 2024

Nov 13, 2024

Earnings call: Wave Life Sciences outlines transformative 2025 outlook By Investing.com - Investing.com Australia

Nov 13, 2024

Nov 13, 2024

Alpha-1 Antitrypsin Deficiency Market Expected to Experience Major Growth by 2034, According to DelveInsight | Kamada Pharma, Mereo BioPharma/AstraZeneca, Grifols Therapeutics LLC, Takeda, Vertex - Barchart

Nov 13, 2024

Nov 13, 2024

Wave Life Sciences (NASDAQ:WVE) Given "Buy" Rating at HC Wainwright - MarketBeat

Nov 13, 2024

Nov 13, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Nov 13, 2024

Earnings call: Wave Life Sciences outlines transformative 2025 outlook - Investing.com

Nov 13, 2024

Nov 13, 2024

WAVE Life Sciences Ltd (WVE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Nov 13, 2024

Nov 12, 2024

Wave Life Sciences’ Q3 2024 Advances in RNA Therapies - TipRanks

Nov 12, 2024

Nov 12, 2024

Wave Life Sciences: Q3 Earnings Snapshot - CT Insider

Nov 12, 2024

Nov 12, 2024

Wave Life Sciences Ltd earnings missed by $0.19, revenue fell short of estimates - Investing.com Nigeria

Nov 12, 2024

Nov 12, 2024

Wave Life Sciences price target raised to $36 from $17 at Truist - TipRanks

Nov 12, 2024

Nov 12, 2024

Wave Life Sciences (WVE) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 12, 2024

Nov 12, 2024

Wave Life Sciences files automatic mixed securities shelf - TipRanks

Nov 12, 2024

Nov 12, 2024

Q3 2024 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus.com

Nov 12, 2024

Nov 12, 2024

Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times

Nov 12, 2024

Nov 12, 2024

Wave Life Sciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

Wave Life Sciences Achieves First-Ever Human RNA Editing, Reports $310.9M Cash Position | WVE Stock News - StockTitan

Nov 12, 2024

Nov 11, 2024

WAVE Life Sciences Ltd (WVE) Q3 2024: Everything You Need to Kno - GuruFocus.com

Nov 11, 2024

Nov 10, 2024

Privium Fund Management B.V. Purchases Shares of 48,834 Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Nov 10, 2024

Nov 09, 2024

Wave Life Sciences (NASDAQ:WVE) Reaches New 12-Month HighStill a Buy? - MarketBeat

Nov 09, 2024

Nov 09, 2024

Optimistic Investors Push Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Up 95% But Growth Is Lacking - Simply Wall St

Nov 09, 2024

Nov 08, 2024

WVE stock surges to 52-week high, touches $15.99 amid robust gains - Investing.com Australia

Nov 08, 2024

Nov 08, 2024

Wave Life Sciences treatment of Huntington’s disease gets FDA orphan designation - TipRanks

Nov 08, 2024

Nov 06, 2024

(WVE) On The My Stocks Page - Stock Traders Daily

Nov 06, 2024

Nov 05, 2024

Wave Life Sciences (WVE) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat

Nov 05, 2024

Nov 05, 2024

Wave Life Sciences (WVE) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance

Nov 05, 2024

Nov 04, 2024

Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024 - StockTitan

Nov 04, 2024

Nov 04, 2024

B. Riley Issues Positive Forecast for Wave Life Sciences (NASDAQ:WVE) Stock Price - MarketBeat

Nov 04, 2024

Nov 03, 2024

Institutional investors in Wave Life Sciences Ltd. (NASDAQ:WVE) see US$94m decrease in market cap last week, although long-term gains have benefitted them. - Yahoo Finance

Nov 03, 2024

Nov 03, 2024

Emerald Advisers LLC Boosts Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Nov 03, 2024